News Sobi stays on its acquisitive streak with $915m Dova deal Sweden’s Sobi has added another already-marketed product to its rare disease portfolio via a $29 per share takeover of Dova
News Envision Pharma Group relocates to larger US offices Envision Pharma Group has opened two new East Coast offices as it seeks larger premises for its New Jersey and Connecticut teams.
News AbbVie gets continuous Parkinson's drug over the line in US AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.